Biosafety—Horizontal Gene Transfer Risk The transfer of antibiotic-resistance genes from genetically engineered bacteria to pathogenic bacteria in natural settings __________.

Difficulty: Easy

Correct Answer: Seems unlikely, but remains a theoretical and low-probability biosafety concern

Explanation:


Introduction / Context:
Horizontal gene transfer (HGT) is the movement of genetic material between organisms outside of parent-to-offspring inheritance. In biotechnology and environmental microbiology, a recurring question is whether engineered antibiotic-resistance markers in laboratory or industrial strains could transfer to pathogens, potentially undermining clinical therapies.


Given Data / Assumptions:

  • HGT mechanisms include transformation, transduction, and conjugation.
  • Engineered strains are often disabled (auxotrophic, non-conjugative) to reduce HGT risk.
  • Environmental exposure, selection pressure, and genetic compatibility modulate risk.


Concept / Approach:
Risk assessment balances plausibility against likelihood. While HGT is biologically possible in principle, well-designed containment, genetic safeguards, and lack of strong selection in the environment make the probability of clinically significant transfer low. Hence, the best answer is that it seems unlikely but remains a theoretical concern, guiding prudent biosafety practices such as markerless constructs or non-clinical resistance markers.


Step-by-Step Solution:

Clarify that “never” is scientifically untenable because HGT exists in nature.Clarify that routine occurrence leading to clinical impact from GM donors is not supported by surveillance data.Conclude that the balanced, precautionary stance is “seems unlikely” yet warrants mitigation.


Verification / Alternative check:
Biocontainment strategies (auxotrophies, kill switches) and field monitoring support very low observed transfer rates from engineered strains in controlled applications.


Why Other Options Are Wrong:

  • No concern: incorrect—any potential for resistance spread deserves caution.
  • Has occurred routinely / guaranteed: overstatements not supported for GM sources.
  • Never: absolute statements are scientifically inappropriate for rare events.


Common Pitfalls:
Equating lab demonstration of HGT with real-world, clinically meaningful dissemination; ignoring selection pressure as the key driver.


Final Answer:
Seems unlikely, but remains a theoretical and low-probability biosafety concern

More Questions from Recombinant DNA Technology

Discussion & Comments

No comments yet. Be the first to comment!
Join Discussion